Skip to main content
Top
Published in: BMC Psychiatry 1/2014

Open Access 01-12-2014 | Research article

Visceral obesity in normal-weight patients suffering from chronic schizophrenia

Authors: Beata Konarzewska, Ewa Stefańska, Agnieszka Wendołowicz, Urszula Cwalina, Anna Golonko, Aleksandra Małus, Urszula Kowzan, Agata Szulc, Leszek Rudzki, Lucyna Ostrowska

Published in: BMC Psychiatry | Issue 1/2014

Login to get access

Abstract

Background

BMI (body mass index) can be misleading regarding the level of adiposity in a normal-weight individual. Recently, a bioelectrical impedance analysis (BIA) method was developed that can measure body composition variables. The main objectives of this study were to use BIA to compare the body composition variables between chronic non-diabetic schizophrenic patients with normal weight and healthy individuals. The secondary objective was to compare the nutritional pattern of schizophrenia patients with that of matched healthy subjects, and to identify possible relationships between the content of different components of their diet and visceral adiposity.

Methods

The subjects were 52 normal-weight patients (33 males and 19 females) diagnosed with schizophrenia based on the DSM-IV and 45 (23 males and 22 females) BMI- matched controls. The patients had been receiving atypical or typical antipsychotic agents for at least one year before enrollment into the study but continuously for 3 months preceding the study and were psychiatrically stable. Body fat (kg), percent (%) body fat, fat-free mass, VAT (visceral adipose tissue) and SAT (subcutaneous adipose tissue) were measured using the bioelectrical impedance analysis (BIA) method. Daily food rations (DFR) were quantitatively evaluated by a 24-h dietary recall method covering 3 days preceding the examination.

Results

In normal-weight patients schizophrenia was significantly linked with higher VAT, VAT/SAT ratio and lower fat- free mass. Men had over 5 times and women over 2 times as much VAT as BMI matched groups. In women with schizophrenia and in their controls, the amount of magnesium, niacin and vitamin B6 in their diet inversely correlated with VAT, while in men lower zinc and vitamin C intake was related to higher visceral adiposity.

Conclusions

Our study has shown that normal-weight patients with chronic schizophrenia have higher levels of visceral fat (VAT) than controls but similar volume of subcutaneous adipose tissue (SAT). Although no clear conclusion can be made regarding cause-and-effect relationships between the dietary content of food served to our patients and visceral obesity, we suggest that schizophrenia diet should be further investigated as a possible factor related to this type of obesity.
Literature
1.
go back to reference Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S: The metabolically obese, normal-weight individual revisited. Diabetes. 1998, 47: 699-713. 10.2337/diabetes.47.5.699.CrossRefPubMed Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S: The metabolically obese, normal-weight individual revisited. Diabetes. 1998, 47: 699-713. 10.2337/diabetes.47.5.699.CrossRefPubMed
2.
go back to reference Björntorp P: Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev. 1988, 4: 615-622. 10.1002/dmr.5610040607.CrossRefPubMed Björntorp P: Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. Diabetes Metab Rev. 1988, 4: 615-622. 10.1002/dmr.5610040607.CrossRefPubMed
3.
go back to reference Carey VJ, Walters EE, Colditz GA, et al: Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses’ health study. Am J Epidemiol. 1997, 145: 614-619. 10.1093/oxfordjournals.aje.a009158.CrossRefPubMed Carey VJ, Walters EE, Colditz GA, et al: Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses’ health study. Am J Epidemiol. 1997, 145: 614-619. 10.1093/oxfordjournals.aje.a009158.CrossRefPubMed
4.
go back to reference Wang J, Liu EY, Freudenreich O, Goff D, Henderson DC, Fan X: Phenotypic characteristics in metabolically obese but normal weight non-diabetic patients with schizophrenia. Schizophr Res. 2010, 124 (1–3): 49-53.CrossRefPubMed Wang J, Liu EY, Freudenreich O, Goff D, Henderson DC, Fan X: Phenotypic characteristics in metabolically obese but normal weight non-diabetic patients with schizophrenia. Schizophr Res. 2010, 124 (1–3): 49-53.CrossRefPubMed
5.
go back to reference Dickerson FB, Brown CH, Kreyenbuhl JA, Fang L, Goldberg RW, Wohlheiter K, Dixon LB: Obesity among individuals with serious mental illness. Acta Psychiatr Scand. 2006, 113: 306-313. 10.1111/j.1600-0447.2005.00637.x.CrossRefPubMed Dickerson FB, Brown CH, Kreyenbuhl JA, Fang L, Goldberg RW, Wohlheiter K, Dixon LB: Obesity among individuals with serious mental illness. Acta Psychiatr Scand. 2006, 113: 306-313. 10.1111/j.1600-0447.2005.00637.x.CrossRefPubMed
6.
go back to reference Susce MT, Villanueva N, Diaz FJ, de Leon J: Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. J Clin Psychiatry. 2005, 66: 167-173. 10.4088/JCP.v66n0203.CrossRefPubMed Susce MT, Villanueva N, Diaz FJ, de Leon J: Obesity and associated complications in patients with severe mental illnesses: a cross-sectional survey. J Clin Psychiatry. 2005, 66: 167-173. 10.4088/JCP.v66n0203.CrossRefPubMed
7.
go back to reference Amani R: Is dietary pattern of schizophrenia patients different from healthy subjects?. BMC Psychiatry. 2007, 7: 1-5. 10.1186/1471-244X-7-1.CrossRef Amani R: Is dietary pattern of schizophrenia patients different from healthy subjects?. BMC Psychiatry. 2007, 7: 1-5. 10.1186/1471-244X-7-1.CrossRef
8.
go back to reference Peet M: Nutrition and schizophrenia: beyond omega-3 fatty acids. Prostaglandins Leukot Essent Fat Acids. 2004, 70: 417-422. 10.1016/j.plefa.2003.12.019.CrossRef Peet M: Nutrition and schizophrenia: beyond omega-3 fatty acids. Prostaglandins Leukot Essent Fat Acids. 2004, 70: 417-422. 10.1016/j.plefa.2003.12.019.CrossRef
9.
go back to reference Pate RR, O’Neill JR, Lobelo F: The evolving defınition of “sedentary”. Exerc Sport Sci Rev. 2008, 36: 173-178. 10.1097/JES.0b013e3181877d1a.CrossRefPubMed Pate RR, O’Neill JR, Lobelo F: The evolving defınition of “sedentary”. Exerc Sport Sci Rev. 2008, 36: 173-178. 10.1097/JES.0b013e3181877d1a.CrossRefPubMed
10.
go back to reference Sharpe JK, Stedman TJ, Byrne NM, Wishart C, Hills AP: Energy expenditure and physical activity in clozapine use: implications for weight management. Aust N Z J Psychiatry. 2006, 40 (12): 810-814.CrossRefPubMed Sharpe JK, Stedman TJ, Byrne NM, Wishart C, Hills AP: Energy expenditure and physical activity in clozapine use: implications for weight management. Aust N Z J Psychiatry. 2006, 40 (12): 810-814.CrossRefPubMed
11.
go back to reference Vancampfort D, Probst M, Knapen J, Carraro A, De Hert M: Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia. Psych Res. 2012, 200 (2/3): 73-78.CrossRef Vancampfort D, Probst M, Knapen J, Carraro A, De Hert M: Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia. Psych Res. 2012, 200 (2/3): 73-78.CrossRef
12.
go back to reference Ryan M, Flanagan S, Kinsella U, Keeling F, Thakore J: The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia. Life Sci. 2004, 74 (16): 1999-2008. 10.1016/j.lfs.2003.08.044.CrossRefPubMed Ryan M, Flanagan S, Kinsella U, Keeling F, Thakore J: The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia. Life Sci. 2004, 74 (16): 1999-2008. 10.1016/j.lfs.2003.08.044.CrossRefPubMed
13.
go back to reference Saarni SE, Saarni SI, Fogelholm M, Heliövaara M, Perälä J, Suvisaari J, Lönnqvist J: Body composition in psychotic disorders: a general population survey. Psychol Med. 2009, 39: 801-810. 10.1017/S0033291708004194.CrossRefPubMed Saarni SE, Saarni SI, Fogelholm M, Heliövaara M, Perälä J, Suvisaari J, Lönnqvist J: Body composition in psychotic disorders: a general population survey. Psychol Med. 2009, 39: 801-810. 10.1017/S0033291708004194.CrossRefPubMed
14.
go back to reference Thakore JH, Mann JN, Vlahos I, Martin A, Reznek R: Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord. 2002, 26: 137-141. 10.1038/sj.ijo.0801840.CrossRefPubMed Thakore JH, Mann JN, Vlahos I, Martin A, Reznek R: Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord. 2002, 26: 137-141. 10.1038/sj.ijo.0801840.CrossRefPubMed
15.
go back to reference Sharpe J, Byrne N, Stedman T, Hills A: Bioelectric impedance is a better indicator of obesity in men with schizophrenia than body mass index. Psychiatry Res. 2008, 159 (1/2): 121-126.CrossRefPubMed Sharpe J, Byrne N, Stedman T, Hills A: Bioelectric impedance is a better indicator of obesity in men with schizophrenia than body mass index. Psychiatry Res. 2008, 159 (1/2): 121-126.CrossRefPubMed
16.
go back to reference Boneva-Asiova Z, Boyanov MA: Body composition analysis by leg-to-leg bioelectrical impedance and dual-energy X-ray absorptiometry in non-obese and obese individuals. Diabetes Obes Metab. 2008, 10: 1012-1018. 10.1111/j.1463-1326.2008.00851.x.CrossRefPubMed Boneva-Asiova Z, Boyanov MA: Body composition analysis by leg-to-leg bioelectrical impedance and dual-energy X-ray absorptiometry in non-obese and obese individuals. Diabetes Obes Metab. 2008, 10: 1012-1018. 10.1111/j.1463-1326.2008.00851.x.CrossRefPubMed
17.
go back to reference Ellis KJ: Human body composition: in vivo methods. Psychol Rev. 2000, 80 (2): 649-680. Ellis KJ: Human body composition: in vivo methods. Psychol Rev. 2000, 80 (2): 649-680.
18.
go back to reference Kitano T, Kitano N, Inomoto T, Futatsuka M: Evaluation of body composition using dual-energy X-ray absorptiometry, skinfold thickness and bioelectrical impedance analysis in Japanese female college students. J Nutr Sci Vitaminol. 2001, 47: 122-125. 10.3177/jnsv.47.122.CrossRefPubMed Kitano T, Kitano N, Inomoto T, Futatsuka M: Evaluation of body composition using dual-energy X-ray absorptiometry, skinfold thickness and bioelectrical impedance analysis in Japanese female college students. J Nutr Sci Vitaminol. 2001, 47: 122-125. 10.3177/jnsv.47.122.CrossRefPubMed
19.
go back to reference Meng-Yueh C, Hsu-Ko K, Ying-Tai W: Sarcopenia, cardiopulmonary fitness, and physical disability in community-dwelling elderly people. Phys Ther. 2010, 90 (9): 1277-1287. 10.2522/ptj.20090322.CrossRef Meng-Yueh C, Hsu-Ko K, Ying-Tai W: Sarcopenia, cardiopulmonary fitness, and physical disability in community-dwelling elderly people. Phys Ther. 2010, 90 (9): 1277-1287. 10.2522/ptj.20090322.CrossRef
20.
go back to reference Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985, 41: 810-817.PubMed Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985, 41: 810-817.PubMed
21.
go back to reference Segal KR, Van Loan M, Fitzgerald PI, et al: Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J CIin Nutr. 1988, 47: 7-14. Segal KR, Van Loan M, Fitzgerald PI, et al: Lean body mass estimation by bioelectrical impedance analysis: a four-site cross-validation study. Am J CIin Nutr. 1988, 47: 7-14.
22.
go back to reference Jackson AS, Pollock ML, Graves JE, Mahar MT: Reliability and validity of bioelectrical impedance in determining body composition. J Appl Physiol. 1988, 64: 529-534.PubMed Jackson AS, Pollock ML, Graves JE, Mahar MT: Reliability and validity of bioelectrical impedance in determining body composition. J Appl Physiol. 1988, 64: 529-534.PubMed
23.
go back to reference Rychlik E: Album fotografii produktów i potraw. 2000, Warszawa: Instytut Żywności i Żywienia Rychlik E: Album fotografii produktów i potraw. 2000, Warszawa: Instytut Żywności i Żywienia
24.
go back to reference Jarosz M: Normy żywienia dla populacji polskiej — nowelizacja. 2012, Warszawa: Instytut Żywności i Żywienia Jarosz M: Normy żywienia dla populacji polskiej — nowelizacja. 2012, Warszawa: Instytut Żywności i Żywienia
25.
go back to reference Ottoson M, Vikman-Adolfson K, Enerback S, Olivecrona G, Bjorntorp P: The effects of cortisol on the regulation of lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metabol. 1994, 79: 820-825. Ottoson M, Vikman-Adolfson K, Enerback S, Olivecrona G, Bjorntorp P: The effects of cortisol on the regulation of lipoprotein lipase activity in human adipose tissue. J Clin Endocrinol Metabol. 1994, 79: 820-825.
26.
go back to reference Sugawara N, Yasui-Furukori N, Tsuchimine S, Fujii A, Sato Y, Saito M, Kaneko S: Body composition in patients with schizophrenia: Comparison with healthy controls. Annals Of General Psychiatry. 2012, 11 (1): 11-15. 10.1186/1744-859X-11-11.CrossRefPubMedPubMedCentral Sugawara N, Yasui-Furukori N, Tsuchimine S, Fujii A, Sato Y, Saito M, Kaneko S: Body composition in patients with schizophrenia: Comparison with healthy controls. Annals Of General Psychiatry. 2012, 11 (1): 11-15. 10.1186/1744-859X-11-11.CrossRefPubMedPubMedCentral
27.
go back to reference Nilsson BM, Forslund AH, Olsson RM, Hambraeus L, Wiesel FA: Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls. Acta Psychiatr Scand. 2006, 114: 27-35. 10.1111/j.1600-0447.2005.00700.x.CrossRefPubMed Nilsson BM, Forslund AH, Olsson RM, Hambraeus L, Wiesel FA: Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls. Acta Psychiatr Scand. 2006, 114: 27-35. 10.1111/j.1600-0447.2005.00700.x.CrossRefPubMed
28.
go back to reference Zhang ZJ, Yao ZJ, Liu W, et al: Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia. Br J Psychiatry. 2004, 184: 58-62. 10.1192/bjp.184.1.58.CrossRefPubMed Zhang ZJ, Yao ZJ, Liu W, et al: Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia. Br J Psychiatry. 2004, 184: 58-62. 10.1192/bjp.184.1.58.CrossRefPubMed
30.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27 (5): 1047-1053. 10.2337/diacare.27.5.1047.CrossRefPubMed
31.
go back to reference Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R: Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993, 21: 1024-1029. 10.1161/01.HYP.21.6.1024.CrossRefPubMed Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R: Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993, 21: 1024-1029. 10.1161/01.HYP.21.6.1024.CrossRefPubMed
32.
go back to reference Huang ES, Liu JY, Moffet HH, John PM, Karter AJ: Glycemic control, complications, and death in older diabetic patients the diabetes and aging study. Diabetes Care. 2011, 34 (6): 1329-1336. 10.2337/dc10-2377.CrossRefPubMedPubMedCentral Huang ES, Liu JY, Moffet HH, John PM, Karter AJ: Glycemic control, complications, and death in older diabetic patients the diabetes and aging study. Diabetes Care. 2011, 34 (6): 1329-1336. 10.2337/dc10-2377.CrossRefPubMedPubMedCentral
33.
go back to reference de Boer IH, Katz R, Cao JJ, Fried LF, Kestenbaum B, Mukamal K, et al: Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care. 2009, 32 (10): 1833-1838. 10.2337/dc09-0191.CrossRefPubMedPubMedCentral de Boer IH, Katz R, Cao JJ, Fried LF, Kestenbaum B, Mukamal K, et al: Cystatin C, albuminuria, and mortality among older adults with diabetes. Diabetes Care. 2009, 32 (10): 1833-1838. 10.2337/dc09-0191.CrossRefPubMedPubMedCentral
34.
go back to reference Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L: Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in postmenopausal women. J Am Coll Nut. 2007, 26 (2): 121-132. 10.1080/07315724.2007.10719593.CrossRef Nielsen FH, Milne DB, Klevay LM, Gallagher S, Johnson L: Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in postmenopausal women. J Am Coll Nut. 2007, 26 (2): 121-132. 10.1080/07315724.2007.10719593.CrossRef
35.
go back to reference Barragan-Rodriguez L, Rodriguez-Moran M, Guerrero-Romero F: Depressive symptoms and hypomagnesemia in older diabetic subjects. Arch Med Res. 2007, 38 (7): 752-756. 10.1016/j.arcmed.2007.03.008.CrossRefPubMed Barragan-Rodriguez L, Rodriguez-Moran M, Guerrero-Romero F: Depressive symptoms and hypomagnesemia in older diabetic subjects. Arch Med Res. 2007, 38 (7): 752-756. 10.1016/j.arcmed.2007.03.008.CrossRefPubMed
36.
go back to reference Dong JY, Xun P, He K, Qin LQ: Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care. 2011, 34 (9): 2116-2122. 10.2337/dc11-0518.CrossRefPubMedPubMedCentral Dong JY, Xun P, He K, Qin LQ: Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care. 2011, 34 (9): 2116-2122. 10.2337/dc11-0518.CrossRefPubMedPubMedCentral
37.
go back to reference Kamanna VS, Kashyap ML: Mechanism of action of niacin on lipoprotein metabolism. Curr Atheroscler Rep. 2000, 2: 36-46. 10.1007/s11883-000-0093-1.CrossRefPubMed Kamanna VS, Kashyap ML: Mechanism of action of niacin on lipoprotein metabolism. Curr Atheroscler Rep. 2000, 2: 36-46. 10.1007/s11883-000-0093-1.CrossRefPubMed
38.
go back to reference Canner PL, Berge KG, Wenger J, Stamler L, Friedman L, Prineas RJ, Friedewald W: Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. Am Coll Cardiol. 1986, 8: 1245-1255. 10.1016/S0735-1097(86)80293-5.CrossRef Canner PL, Berge KG, Wenger J, Stamler L, Friedman L, Prineas RJ, Friedewald W: Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. Am Coll Cardiol. 1986, 8: 1245-1255. 10.1016/S0735-1097(86)80293-5.CrossRef
39.
go back to reference Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino E, Bolson E, Alaupovic PJ, Frohlich J, Albers JJ: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001, 345: 1583-1592. 10.1056/NEJMoa011090.CrossRefPubMed Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino E, Bolson E, Alaupovic PJ, Frohlich J, Albers JJ: Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001, 345: 1583-1592. 10.1056/NEJMoa011090.CrossRefPubMed
40.
go back to reference Young SN, Gauthier S: Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid, and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1981, 44: 323-327. 10.1136/jnnp.44.4.323.CrossRefPubMedPubMedCentral Young SN, Gauthier S: Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid, and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1981, 44: 323-327. 10.1136/jnnp.44.4.323.CrossRefPubMedPubMedCentral
41.
go back to reference Wurtman RJ, Wurtman JJ: Brain serotonin, carbohydrate-craving, obesity and depression. Obes Res. 1995, 4: 477-480.CrossRef Wurtman RJ, Wurtman JJ: Brain serotonin, carbohydrate-craving, obesity and depression. Obes Res. 1995, 4: 477-480.CrossRef
42.
go back to reference Chen MD, Lin PY, Lin WH, Cheng V: Zinc in hair and serum of obese individuals in Taiwan. Am J Clin Nutr. 1988, 48: 1307-1309.PubMed Chen MD, Lin PY, Lin WH, Cheng V: Zinc in hair and serum of obese individuals in Taiwan. Am J Clin Nutr. 1988, 48: 1307-1309.PubMed
43.
go back to reference Liuzzi JP, Lichten LA, Rivera S, Blanchard SK, Aydemir TB, Knutson MD, Ganz T, Cousins RJ: Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci USA. 2005, 102: 6843-6848. 10.1073/pnas.0502257102.CrossRefPubMedPubMedCentral Liuzzi JP, Lichten LA, Rivera S, Blanchard SK, Aydemir TB, Knutson MD, Ganz T, Cousins RJ: Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci USA. 2005, 102: 6843-6848. 10.1073/pnas.0502257102.CrossRefPubMedPubMedCentral
44.
go back to reference Gariballa , et al: Oxidative damage and inflammation in obese diabetic Emirati subjects supplemented with antioxidants and B-vitamins: a randomized placebo-controlled trail. Nutr Metab. 2013, 10: 21-10.1186/1743-7075-10-21.CrossRef Gariballa , et al: Oxidative damage and inflammation in obese diabetic Emirati subjects supplemented with antioxidants and B-vitamins: a randomized placebo-controlled trail. Nutr Metab. 2013, 10: 21-10.1186/1743-7075-10-21.CrossRef
45.
go back to reference Puchau B, Zulet A, Gonzalez A, Hermsdorff H, Martinez J: Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young men. Nutrition. 2010, 26: 534-541. 10.1016/j.nut.2009.06.017.CrossRefPubMed Puchau B, Zulet A, Gonzalez A, Hermsdorff H, Martinez J: Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young men. Nutrition. 2010, 26: 534-541. 10.1016/j.nut.2009.06.017.CrossRefPubMed
Metadata
Title
Visceral obesity in normal-weight patients suffering from chronic schizophrenia
Authors
Beata Konarzewska
Ewa Stefańska
Agnieszka Wendołowicz
Urszula Cwalina
Anna Golonko
Aleksandra Małus
Urszula Kowzan
Agata Szulc
Leszek Rudzki
Lucyna Ostrowska
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2014
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-14-35

Other articles of this Issue 1/2014

BMC Psychiatry 1/2014 Go to the issue